Judge OKs $486M Celebrex, Bextra Securities MDL Deal
By John Kennedy ( September 19, 2016, 3:25 PM EDT) -- A New York federal judge on Friday preliminarily approved Pfizer Inc.'s $486 million settlement resolving long-running multidistrict litigation accusing the company of misleading investors about the alleged risks of its pain treatments Celebrex and Bextra and set a final approval hearing for Dec. 21....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.